|
|
||||||||


* Institute of Immunology, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway; and
Department of Chemistry, Stanford University, Stanford, CA 94305
Celiac disease is an HLA-DQ2-associated disorder characterized by intestinal T cell responses to ingested wheat gluten proteins. A peptide fragment of 33 residues (
2-gliadin 5688) produced by normal gastrointestinal proteolysis contains six partly overlapping copies of three T cell epitopes and is a remarkably potent T cell stimulator after deamidation by tissue transglutaminase (TG2). This 33-mer is rich in proline residues and adopts the type II polyproline helical conformation in solution. In this study we report that after deamidation, the 33-mer bound with higher affinity to DQ2 compared with other monovalent peptides harboring gliadin epitopes. We found that the TG2-treated 33-mer was presented equally effectively by live and glutaraldehyde-fixed, EBV-transformed B cells. The TG2-treated 33-mer was also effectively presented by glutaraldehyde-fixed dendritic cells, albeit live dendritic cells were the most effective APCs. A strikingly increased T cell stimulatory potency of the 33-mer compared with a 12-mer peptide was also seen with fixed APCs. The 33-mer showed binding maximum to DQ2 at pH 6.3, higher than maxima found for other high affinity DQ2 binders. The 33-mer is thus a potent T cell stimulator that does not require further processing within APC for T cell presentation and that binds to DQ2 with a pH profile that promotes extracellular binding.
This article has been cited by other articles:
![]() |
M. T. Bethune, M. Siegel, S. Howles-Banerji, and C. Khosla Interferon-{gamma} Released by Gluten-Stimulated Celiac Disease-Specific Intestinal T Cells Enhances the Transepithelial Flux of Gluten Peptides J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 657 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Camarca, R. P. Anderson, G. Mamone, O. Fierro, A. Facchiano, S. Costantini, D. Zanzi, J. Sidney, S. Auricchio, A. Sette, et al. Intestinal T Cell Responses to Gluten Peptides Are Largely Heterogeneous: Implications for a Peptide-Based Therapy in Celiac Disease J. Immunol., April 1, 2009; 182(7): 4158 - 4166. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tunheim, K. W. Schjetne, I. B. Rasmussen, L. M. Sollid, I. Sandlie, and B. Bogen Recombinant antibodies for delivery of antigen: a single loop between {beta}-strands in the constant region can accommodate long, complex and tandem T cell epitopes Int. Immunol., March 1, 2008; 20(3): 295 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Matysiak-Budnik, I. C. Moura, M. Arcos-Fajardo, C. Lebreton, S. Menard, C. Candalh, K. Ben-Khalifa, C. Dugave, H. Tamouza, G. van Niel, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease J. Exp. Med., January 21, 2008; 205(1): 143 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gass, H. Vora, M. T. Bethune, G. M. Gray, and C. Khosla Effect of Barley Endoprotease EP-B2 on Gluten Digestion in the Intact Rat J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1178 - 1186. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Israel, L. L. Levitsky, S. A. Anupindi, and M. B. Pitman Case 3-2005 - A 14-Year-Old Boy with Recent Slowing of Growth and Delayed Puberty N. Engl. J. Med., January 27, 2005; 352(4): 393 - 403. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |